* Bouazza, N., Cambonie, G., Flamant, C., Rideau, A., Tauzin, M., Patkai, J., et al. Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach. Paediatr Drugs, 2023 Nov 17. DOI: 10.1007/s40272-023-00602-w

Download the questionnaire

Here you can download the parental questionnaire for the TREOCAPA-LT study. Vous pouvez télécharger ici le questionnaire parental de l’étude TREOCAPA-LT. French questionnaire – Questionnaire pour la France :

Potential risks and benefits

The aim of this study is to improve medical and scientific knowledge about the neurodevelopment of children who receive paracetamol at birth for closure of the ductus arteriosus. The objectives and benefits of this research are therefore not individual, but aim to improve the health and development of children born preterm. There are no risks… Continue reading Potential risks and benefits

Patient information sheet

Here you can download the patient information sheet for the TREOCAPA-LT study. Vous pouvez télécharger ici la notice d’information parent de l’étude TREOCAPA-LT French Leaflet – Notice d’information pour la France :

Funding, sponsorship and coordination

The TREOCAPA-LT study is funded through the MESSIDORE (Méthodologie des ESSais cliniques Innovants, Dispositifs, Outils et Recherches Exploitant les données de santé et biobanques — Innovative clinical trials methodology, Devices, tools and research using health data and biobanks) 2022 Strategic Program for Collaborative Health Research run by Inserm, the French National Institute of Health and… Continue reading Funding, sponsorship and coordination


TREOCAPA-LT follows up the children at the age of two who participated in the TREOCAPA trial using an online questionnaire completed by their parents. The aim is to determine whether the preventive use of paracetamol in preterm infants during the first five days of life is safe and effective in reducing the risk of neurodevelopmental… Continue reading TREOCAPA-LT

Factsheet designed by EFCNI

EFCNI designed a factsheet for parents and caregivers to raise awareness on the importance of clinical trials in newborns using the TREOCAPA study as an example. The factsheet is available on EFCNI’s website : click on the picture below ! This facsheet is also available in other languages : click here to consult them :… Continue reading Factsheet designed by EFCNI

For Investigators

In this section you will find information that may be of interest to investigators participating in Treocapa. Newsletter : click on the NL to view it NL 17 – April 2023 NL 16 – March 2023 NL 15 – Feb 2023 NL 14 – Sept 2022 NL 13 – May 2022 NL 12 – April… Continue reading For Investigators

EFCNI: European Foundation for the Care of Newborn Infants

The European Foundation for the Care of Newborn Infants (EFCNI) is the official Patient and Public Involvement (PPI) partner of the TREOCAPA study. What is EFCNI? The European Foundation for the Care of Newborn Infants (EFCNI) is a pan-European organisation and network which represents the interests of preterm and newborn infants and their families. Its… Continue reading EFCNI: European Foundation for the Care of Newborn Infants